Hope those who chased this name after the recent $新基(CELG)$ collaboration information knows about this:
80% of locked-up shares have expired (highest as far as I know in recent biotech names). I have mentioned this before.
IMHO, the lock-up flush has not finished. I have no further comment on this.
Good luck!